Deferred Tax Assets, Valuation Allowance of Aptevo Therapeutics Inc. from 31 Dec 2015 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Aptevo Therapeutics Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2015 to 31 Dec 2024.
  • Aptevo Therapeutics Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $49,180,000, a 7.6% decline year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Aptevo Therapeutics Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $49,180,000 -$4,037,000 -7.6% 31 Dec 2024 10-K 14 Feb 2025 2024 FY
Q4 2023 $53,217,000 +$4,104,000 +8.4% 31 Dec 2023 10-K 14 Feb 2025 2024 FY
Q4 2022 $49,113,000 -$1,132,000 -2.3% 31 Dec 2022 10-K 05 Mar 2024 2023 FY
Q4 2021 $50,245,000 +$5,954,000 +13% 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q4 2020 $44,291,000 +$4,396,000 +11% 31 Dec 2020 10-K 24 Mar 2022 2021 FY
Q4 2019 $39,895,000 +$9,586,000 +32% 31 Dec 2019 10-K 31 Mar 2021 2020 FY
Q4 2018 $30,309,000 +$13,162,000 +77% 31 Dec 2018 10-K 25 Mar 2020 2019 FY
Q4 2017 $17,147,000 -$12,670,000 -42% 31 Dec 2017 10-K 18 Mar 2019 2018 FY
Q4 2016 $29,817,000 -$104,672,000 -78% 31 Dec 2016 10-K 13 Mar 2018 2017 FY
Q4 2015 $134,489,000 31 Dec 2015 10-K 31 Mar 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.